Moreover, shRNA-mediated depletion of MDC1 resulted in olaparib resistance in the human high-grade serous ovarian cancer cell line PEO1, that carries the BRCA2 c.5193C>G mutation leading to a complete loss of protein stability (Fig. 1F, G). This evidence concerns the gene BRCA2 and ovarian serous adenocarcinoma.